When sugar damages kidneys
New hope for diabetes patients with kidney disease
Björn Hartleben and Martin Helmstädter
Prof. Dr. Tobias Huber is a kidney expert in the Nephrology Division of the University Medical Center Freiburg. With the support of the Cluster of Excellence BIOSS – Centre for Biological Signalling Studies, Dr. Huber and his team were able to identify a signalling path that affects the progression of kidney disease in diabetes patients: mTOR is an important metabolic enzyme that controls similar functions in simple organisms, such as yeast and roundworms, as in humans; for example, it controls the growth and reproduction of cells. Diabetes causes the mTOR signalling path to become overactive, which can cause damage in highly specialized kidney cells.
The researchers in Freiburg were able to demonstrate that, although the basal activation of this enzyme may be important for the regular function of renal corpuscles during embryonic development, an overactive mTOR can result in a serious disruption of the kidney filter in diabetes patients and can lead to a total loss of function. In tests on animals, the deliberate genetic interception of this signalling path was able to halt the progression of kidney disease.
This result also gives us hope that it will be possible to prevent kidney disease in diabetes patients in the future.
Dr. Huber was also honoured last year with the highest scientific award in Germany for kidney research, the Franz Volhard Award, for his achievements in the field of kidney filtration.
Original publication
Other news from the department science
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.